Treatment for Endothelial Dysfunction

Phase-Based Progress Estimates
M D Anderson Cancer Center, Houston, TX
Endothelial Dysfunction+3 More
< 65
All Sexes
Eligible conditions

Study Summary

This study is evaluating whether a device can be used to measure vascular reactivity in children and young adults undergoing hematopoietic cell transplantation.

See full description

Eligible Conditions

  • Endothelial Dysfunction
  • Endothelial
  • Endothelix
  • Vascular

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

This trial is evaluating whether Treatment will improve 1 primary outcome in patients with Endothelial Dysfunction. Measurement will happen over the course of through study completion, an average of 1 year.

Year 1
The use of VENDYS-II in children and AYA as a measure of vascular endothelial function.

Trial Safety

Safety Progress

1 of 3

Trial Design

0 Treatment Group

This trial requires 50 total participants across 0 different treatment group

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: through study completion, an average of 1 year
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly through study completion, an average of 1 year for reporting.

Closest Location

M D Anderson Cancer Center - Houston, TX

Eligibility Criteria

This trial is for patients born any sex aged 65 and younger. There are 5 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
- Healthy HCT donors between the ages of 6-26 years of age.
Willing and eligible to enroll on PA19-0756
Children, adolescents and young adults (AYA) 6-26 years of age who are HCT candidates
Recipients within 30 days prior to or within 14 days after autologous and allogeneic HCT.
-. Any preparative regimen.

Patient Q&A Section

Ask a question about the study

Other questions from users

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any geographic restrictions to consider when applying for this trial?

Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.

Will my insurance cover participating in this trial?

In order to understand how insurance coverage works for this trial, you will need to contact the study coordinator.

See if you qualify for this trial
Get access to this novel treatment for Endothelial Dysfunction by sharing your contact details with the study coordinator.